TITLE

Circulatory Effects of Intravenous and Oral Atenolol in Acute Myocardial Infarction

AUTHOR(S)
Midtbø, K.; Silke, B.; Verma, S. P.; Reynolds, G. W.; Hafizullah, M.; Taylor, S. H.
PUB. DATE
September 1988
SOURCE
Angiology;Sep1988, Vol. 39 Issue 9, p795
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The hemodynamic dose-response effects of intravenous (0.05 and 0.10 and oral (50 and 100 mg) atenolol were compared in a randomized between-group study of 24 men within seventeen hours of an acute uncomplicated myocardial infarction; 6 subjects were evaluated in each of the four groups. Hemodynamic variables were determined over a one-hour control period, following which the randomized dose of atenolol was administered and measurements repeated at 15 (intravenous therapy only), 30, 60, 90, 120, 180, 240, 300, and 360 minutes. The peak hemodynamic effect was similar and independent of either the dosage or route of administration. In all groups atenolol reduced heart rate and cardiac and stroke volume indices. The pulmonary artery occluded pressure and systemic vascular resistance index were transiently increased. Mean arterial pressure was significantly reduced only in the oral group with the highest pretreatment pressure. Maximum changes developed between fifteen and thirty minutes after intravenous dosing and between two and three hours after oral dosing. However, substantial reductions in cardiac index (-0.6 L/min/m2; p < 0.05) were already achieved at sixty minutes following oral dosing. The duration of pharmacodynamic activity was for two to three hours following intravenous and for the study duration (four to six hours) after oral dosing. These data confirm the hemodynamic safety of atenolol after acute myocardial infarction.
ACCESSION #
16346146

 

Related Articles

  • atenolol.  // Royal Society of Medicine: Medicines;2002, p91 

    This article presents information on beta-blocker atenolol. The drug can be used as an antihypertensive for raised blood pressure, as an anti-angina treatment to relieve symptoms and to improve exercise tolerance, to regularize heartbeat and after anti-arrhythmic myocardial infarction. Atenolol...

  • Atenolol: Use with caution. Motylev, Alexander // Drug Topics;11/21/2005, Vol. 149 Issue 22, pHSE2 

    This article examines the effectiveness of selective beta 1-blocker atenolol for blood pressure control. Studies have reported that the selective beta 1-blocker atenolol, at doses of 50 to 100 milligrams, produced higher cardiovascular mortality and stroke risk rates compared with other...

  • Simultaneous UV-Spectrophotometric Method for the Estimation of Atenolol and Amlodipine Besylate in Combined Dosage Form. Kasture, A. V.; Ramteke, Madhuri // Indian Journal of Pharmaceutical Sciences;2006, Vol. 68 Issue 3, p394 

    Simple, accurate, and precise UV-Spectrophotometric method was developed for the estimation of atenolol and amlodipine besylate in tablets. The standard stock solutions of atenolol and amlodipine besylate as well as mixed standard solution were diluted appropriately. The absorption spectra of...

  • Review: β-blockers are less effective than other antihypertensive drugs for reducing risk for stroke in primary hypertension.  // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p67 

    The article discusses a study which determines whether β-blockers are more effective than placebo or other antihypertensive drugs for reducing stroke, myocardial infarction and all-cause mortality in patients with primary hypertension. β-blockers were compared with placebo or no treatment...

  • Betim.  // Royal Society of Medicine: Medicines;2002, p113 

    The article presents information on Betim, a proprietary, prescription-only preparation drug of the beta-blocker timolol maleate. This drug can used as an antihypertensive for high blood pressure, as an anti-angina treatment to relieve symptoms and improve exercise tolerance and to treat...

  • Safety fears stop beta-blocker trial. Baines, Emma // GP: General Practitioner;12/17/2004, p2 

    This article informs that a large drug trial has been stopped early after it was found that patients treated with beta-blockers and thiazides were more likely to have a cardiovascular event than those in the group who were given newer antihypertensive treatment. This could mean that...

  • Computer-assisted design for atenolol prodrugs for the use in aqueous formulations. Karaman, Rafik; Dajani, Khuloud; Hallak, Hussein // Journal of Molecular Modeling;Apr2012, Vol. 18 Issue 4, p1523 

    Based on stability studies on the drugs atenolol and propranolol and some of their derivatives it is believed that increasing the lipophilicity of the drug will lead to an increase in the stability of its aqueous solutions and will provide a prodrug system with the potential for releasing...

  • An Effective RP-HPLC Method for the Simultaneous Determination of Atenolol and Indapamide in Marketed Tablet Formulation (ATEN-D). Kadian, Naveen; Maste, Meenaxi; Bhat, A. R. // Asian Journal of Research in Chemistry;Mar2012, Vol. 5 Issue 3, p405 

    In the present study a simple, sensitive, accurate and effective Reverse Phase High-Performance liquid chromatographic (RP- HPLC) method was developed for the determination of Atenolol and Indapamide simultaneously in the tablets. The analysis was resolved by using a mobile phase methanol: water...

  • Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study. Dunder, Kristina; Lind, Lars; Zethelius, Bjorn; Berglund, Lars; Lithell, Hans // BMJ: British Medical Journal (International Edition);3/29/2003, Vol. 326 Issue 7391, p681 

    Abstract Objective: To investigate the impact of an increase in blood glucose on the risk of developing myocardial infarction, with particular emphasis on people taking antihypertensive drugs. Design: Prospective population based cohort study. Setting: Uppsala, Sweden. Participants: 1860 men who...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics